Zusammenfassung
Diabetes mellitus Typ 2 ist die häufigste Form des Diabetes mellitus (▸ s.Kap.1). Während im Zentrum der Pathogenese des Typ-1-Diabetes die Zerstörung der β-Zellen und das Versagen der Insulinsekretion stehen, wird bei Typ-2-Diabetes als Ursache eine primäre Insulinresistenz bei gleichzeitig gestörter Insulinsekretion angesehen.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Anderwald A, Bernroider E, Krssak M et al (2002) Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes 51:3025–3032
Anderwald Ch, Brabant G, Bernroider E et al (2003) Insulin dependent modulation of plasma Ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients. Diabetes 52:1792–1798
Bell Gl, Polonsky KS (2001) Diabetes mellitus and genetically programmed defects in β-cell function. Nature 414: 788–791
Bratusch-Marrain P, Waldhäusl W (1987) Hepatische und periphere Insulinresistenz als Ursache der Hyperglykämie bei nichtinsulinabhängigem (Typ-2)-Diabetes-mellitus. Wiener klinische Wochenschrift 99:211–217
Charles MA, Eschwege E, Thibult N et al (1997) The role of nonesterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris prospective study. Diabetologia 40:1101–1106
DeFronzo RA (1988) The triumvirate b-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37:667–687
Evans JL Goldfine ID, Maddux BA, Grodsky GM (2002) Oxidative stress and stress-activated signalling pathways: a unifying hypothesis of type 2 diabetes. Endocrine Reviews 23: 599–622
Fürnsinn C, Leuvenink H, Roden M et al (1994) Islet amyloid polypeptide inhibits insulin secretion in conscious rats. Am J Physiol 267: E300–E305
Krssak M, Petersen KF, Dresner A et al (1999) Intramyocellular lipid concentrations are correlated with insulin sensitivity in human: a 1H NMR spectroscopy study. Diabetologia 42: 113–116
McGarry JD, Dobbins RL (1999) Fatty acids, lipotoxicity and insulin secretion. Diabetologia 42:128–138
Neel J (1962) Diabetes mellitus: a thrifty genotype rendered detrimental by ‘progress’? Am J Hum Genet 14:353–362
Odom DT, Zizlsperger N, Gordon DB et al (2004) Control of pancreas and liver gene expression by HNF transcription factors. Science 203:1378–1381
Paolisso G, Tortarini PA, Foley JE et al (1995) A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 38: 1213–1217
Petersen KF, Betroy D, Dufour S et al (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140–1142
Pickup JC, Mattock MB, Chusney GD, Burt D (1997) NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40:1286–1292
Poitout V, Robertson RP (2002) Minireview: Secondary β-cell failure in type 2 diabetes — a convergence of glucotoxicity and lipotoxicity. Endocrinology 143:339–342
Polonsky KS, Given BD, Hirsch LJ et al (1988) Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med 318:1231–1239
Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H (1999) Heritability of type 2 (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance — a population based twinstudy. Diabetologia 42:139–145
Reaven G (1995) The fourth musketeer — from Alexander Dumas to Claude Bernard. Diabetologia 38:3–13
Roden M, Price TB, Perseghin G et al (1996) Mechanism of free fatty acid induced insulin resistance in humans. J Clin Invest 97:2859–2865
Roden M, Krssak M, Stingl H et al (1999) Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in man. Diabetes 48:358–364
Saltiel AR, Kahn R (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799–806
Waldhäusl W, Bratusch-Marrain P, Gasic S et al (1982) Insulin production rate, hepatic insulin retention and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinemic type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 23:6–15
Waldhäusl W, Bratusch-Marrain P, Kruse V et al (1985) Effect of insulin antibodies on pharmacokinetics and glucose utilization in insulin dependent diabetic patients. Diabetes 34:166–172
Waldhäusl W, Roden M (2000) The effect of free fatty acids on glucose transport and phosphorylation in human skeletal muscle. Curr. Opin. Endocrinol. Diabetes 7:211–216
Zimmet P, AIberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782–787
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Waldhäusl, W., Roden, M. (2004). Diabetes mellitus Typ 2: Ätiologie und Pathogenese. In: Waldhäusl, W.K., Gries, F.A., Scherbaum, W.A. (eds) Diabetes in der Praxis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18571-7_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-18571-7_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62166-6
Online ISBN: 978-3-642-18571-7
eBook Packages: Springer Book Archive